149 related articles for article (PubMed ID: 35271937)
1. Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.
Moreno-Ramírez D; Duarte-Ferreras MA; Ojeda-Vila T; García-Morales I; Conejo-Mir MD; Fernández-Orland A; Sánchez-Del-Campo AI; Eiris N; Carrizosa AM; Ruiz-de-Casas A; de-la-Torre JM; Herrerías-Esteban JM; Ferrándiz L
J Am Acad Dermatol; 2022 Nov; 87(5):1186-1189. PubMed ID: 35271937
[No Abstract] [Full Text] [Related]
2. Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospital.
Demirel Öğüt N; Kutlu Ö; Erbağcı E
J Cosmet Dermatol; 2021 Jul; 20(7):1969-1974. PubMed ID: 33884755
[TBL] [Abstract][Full Text] [Related]
3. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic.
Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D
Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565
[TBL] [Abstract][Full Text] [Related]
4. Acne fulminans and isotretinoin: case report.
Pereira MF; Roncada EM; Oliveira CM; Monteiro R; Abreu MA; Ortigosa LC
An Bras Dermatol; 2011; 86(5):983-5. PubMed ID: 22147039
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin-induced Acne Fulminans without Systemic Symptoms Treated Successfully with Oral Dapsone.
Legal K; Misery L
Acta Derm Venereol; 2020 Jan; 100(1):adv00036. PubMed ID: 31626323
[No Abstract] [Full Text] [Related]
6. Pseudo-acne fulminans associated with oral isotretinoin.
Grando LR; Leite OG; Cestari TF
An Bras Dermatol; 2014; 89(4):657-9. PubMed ID: 25054758
[TBL] [Abstract][Full Text] [Related]
7. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
[TBL] [Abstract][Full Text] [Related]
8. Myths of isotretinoin therapy in patients with acne: a personal opinion.
Alcalay J
J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
[TBL] [Abstract][Full Text] [Related]
9. New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
Elnady B; Elkhouly T; Dawoud NM; Desouky DE; Kewan HH; Dawoud DM; Ritchlin C
Clin Rheumatol; 2020 Jun; 39(6):1829-1838. PubMed ID: 32034553
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin-induced acne fulminans without systemic symptoms with concurrent exuberant granulation tissue.
Li AW; Antaya RJ
Pediatr Dermatol; 2018 Mar; 35(2):257-258. PubMed ID: 29314240
[TBL] [Abstract][Full Text] [Related]
11. Acne fulminans induced by a low dose isotretinoin: case report and review of the literature.
Fakih A; Goens J; Grozdev I; Dangoisse C; Richert B
Dermatol Online J; 2020 Dec; 26(12):. PubMed ID: 33423422
[TBL] [Abstract][Full Text] [Related]
12. Is oral isotretinoin the treatment of choice in moderate and severe inflammatory acne vulgaris?
Verros CD; Rallis E
J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1270-1. PubMed ID: 17894728
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of systemic isotretinoin treatment for moderate to severe acne (insights from the real-life clinical setting).
Tolino E; Skroza N; Proietti I; Mambrin A; Balduzzi V; Marchesiello A; Maddalena P; Michelini S; Volpe S; Bernardini N; Potenza C
Dermatol Ther; 2020 Nov; 33(6):e14392. PubMed ID: 33037685
[TBL] [Abstract][Full Text] [Related]
14. Acne, isotretinoin and depression.
Drug Ther Bull; 2003 Oct; 41(10):76-8. PubMed ID: 14593974
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D level in patients with moderate-to-severe acne: A case-control study combined with prospective study following oral isotretinoin treatment.
Shrestha S; Agrawal S; Lamsal M
J Cosmet Dermatol; 2022 Oct; 21(10):5127-5133. PubMed ID: 35429216
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence.
Gualtieri B; Panduri S; Chiricozzi A; Romanelli M
G Ital Dermatol Venereol; 2020 Jun; 155(3):361-362. PubMed ID: 30229637
[No Abstract] [Full Text] [Related]
17. Novel management of isotretinoin-induced hypertriglyceridemia in an adolescent with severe acne.
Beach RA; McQueen M; Wismer J
Clin Pediatr (Phila); 2009 Jun; 48(5):551-4. PubMed ID: 19246414
[No Abstract] [Full Text] [Related]
18. Mobile teledermatology helping patients control high-need acne: a randomized controlled trial.
Frühauf J; Kröck S; Quehenberger F; Kopera D; Fink-Puches R; Komericki P; Pucher S; Arzberger E; Hofmann-Wellenhof R
J Eur Acad Dermatol Venereol; 2015 May; 29(5):919-24. PubMed ID: 25258175
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of the responsiveness of depression and suicidal ideation in acne patients to different phases of isotretinoin therapy.
Kellett SC; Gawkrodger DJ
Eur J Dermatol; 2005; 15(6):484-8. PubMed ID: 16280305
[TBL] [Abstract][Full Text] [Related]
20. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort.
Cohen J; Adams S; Patten S
Can J Clin Pharmacol; 2007; 14(2):e227-33. PubMed ID: 17556790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
